Testing effectiveness (Phase 2)Study completedNCT02474199
What this trial is testing
Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Who this might be right for
Liver Transplant RecipientLiving Donor (of the Respective Liver Transplant Recipient)
National Institute of Allergy and Infectious Diseases (NIAID) 15